logo

ME(Delisted)

23andMeยทNASDAQ
--
--(--)

ME Profile

23andme Holding Co.

A genetics-led consumer healthcare and therapeutics company

--
02/19/2020
06/17/2021
NASDAQ Stock Exchange
560
03-31
Common stock
349 Oyster Point Boulevard, South San Francisco, California 94080
--
23andMe Holding Co., incorporated in Delaware on February 19, 2020, is a leading consumer genetics and research company. Its mission is to help people acquire, understand and benefit from the human genome. 23andMe is the first to have direct access to genetic information and is the only genetic health risk reporting company with multiple FDA authorizations. 23andMe has created the world's largest crowdsourcing platform for genetic research, with 80 percent of its customers choosing to participate.